NovoCure (FRA:038) Days Sales Outstanding : 43.58 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is NovoCure Days Sales Outstanding?

NovoCure's average Accounts Receivable for the three months ended in Dec. 2023 was €58.6 Mil. NovoCure's Revenue for the three months ended in Dec. 2023 was €122.7 Mil. Hence, NovoCure's Days Sales Outstanding for the three months ended in Dec. 2023 was 43.58.

The historical rank and industry rank for NovoCure's Days Sales Outstanding or its related term are showing as below:

FRA:038' s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.91 Med: 51.2 Max: 64.9
Current: 51.37

During the past 11 years, NovoCure's highest Days Sales Outstanding was 64.90. The lowest was 27.91. And the median was 51.20.

FRA:038's Days Sales Outstanding is ranked better than
66.91% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs FRA:038: 51.37

NovoCure's Days Sales Outstanding declined from Dec. 2022 (63.92) to Dec. 2023 (43.58).

NovoCure Days Sales Outstanding Historical Data

The historical data trend for NovoCure's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure Days Sales Outstanding Chart

NovoCure Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

49.11

59.49

62.55

59.03

53.75

NovoCure Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															63.92	60.50	53.10	48.40	43.58

Competitive Comparison of NovoCure's Days Sales Outstanding

For the Medical Devices subindustry, NovoCure's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovoCure's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NovoCure's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NovoCure's Days Sales Outstanding falls into.

NovoCure Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NovoCure's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (81.43	+	56.14)	/	2 )	/	467.063	*	365
=	68.785					/	467.063	*	365
=	53.75

NovoCure's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (61.03	+	56.14)	/	2 )	/	122.68	*	365 / 4
=	58.585					/	122.68	*	365 / 4
=	43.58

NovoCure (FRA:038) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NovoCure Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NovoCure's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NovoCure (FRA:038) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NovoCure Ltd (FRA:038) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

NVCR:USA 038:Germany

Address

Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF

Website

https://www.novocure.com

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. Products are comprised of two main components: electric field generator and arrays and related accessories. NovoCure derives its major revenues in the United States.

NovoCure (FRA:038) Headlines

No Headlines